Residents and Fellows Research in Progress
Monday, November 13, 2023
01:00 PM–02:30 PM
Abstract
Introduction: The use of continuous glucose monitor (CGM) is recommended for all patients with diabetes treated with daily insulin injection(s). Several studies have demonstrated the beneficial effects of CGM use for reducing HbA1c and decreasing hypoglycemic events.
When CGMs are used, blood glucose (BG) levels between 70-180 mg/dL are considered “in range” and a time in range (TIR) of >70% is predictive of an HbA1c <7%. Despite the robust evidence supporting CGM use, successful utilization of CGM remains relatively low at this time.
Research Question or Hypothesis: What percentage of patients using a CGM are achieving BG goals and what specific patient characteristics are associated with achievement of glycemic targets when using a CGM?
Study Design: Retrospective, observational review of adult patients with type 1 or 2 diabetes or latent autoimmune diabetes receiving care at an endocrinology office or primary care clinic affiliated with a large, academic medical center.
Methods: Patients were included if they used a CGM for >6 months consecutively, with a percent active time of =70%. Key exclusion criteria included gestational diabetes, pregnancy, and non-adherence. The primary outcome is to determine the percentage of patients who achieve a TIR of = 70% (at goal) within 6 months of starting CGM. Secondary outcomes are to assess patient characteristics associated with achieving TIR goals and describe clinical pharmacist involvement with patients throughout the study period. Data will be collected via chart review from CGM data-sharing platforms and the electronic medical record by a single investigator. Bivariate analysis and multiple logistic regression will be used to evaluate the primary outcome and identify patient variables associated with achievement of TIR goals. Descriptive statistics will be used for all other variables.
Results: This study is ongoing.
Conclusion: Results of this study will help refine the role of CGM use in various practice settings and patient populations.
Presenting Author
Robert Adams PharmD, MAUniversity of Rochester Medical Center
Authors
Faezeh Azizi PharmD
University of Rochester Medical Center
Samantha Heacock PharmD, BCACP, BC-ADM
University of Rochester Medical Center
Katherine Diehl PharmD, BCACP
University of Rochester Medical Center
Lauren Enser PharmD, BCACP
University of Rochester Medical Center